Crispr Therapeutics Stock Been: A Roller-Coaster Year Unpacked
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Learn Warren Buffett's investment strategy for beginners. Gain valuable insights from a legendary investor to guide your choices.
21,355 articlesCRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
A growing share of retirees split time across states, exposing gaps in coverage from Medicare Advantage plans. Origin...
Amazon delivered strong AWS growth and solid Q1 results, but a large capex plan keeps investors wary. Still, a broad ...
Micron Technology rides the AI memory wave, but a blowout earnings report invites questions. This guide breaks down t...
The 2026 update to Social Security reveals a widening gap between income and costs, with a $160 billion social securi...
The S&P 500 just delivered its just best quarter since 2020, sparking questions about the path ahead. This article br...
AI’s hardware backbone goes beyond chips. This deep dive explains why Vertiv and Eaton are pivotal to the AI boom, fr...
Alibaba leads a broad rally in China’s tech and e-commerce sector as investors brace for quarterly results. Baidu and...
Two semiconductor giants vie for AI-led growth. This article breaks down how revenue growth rates and company scale s...
London-based Valarian secures a $50 million Series A led by NEA to deploy ACRA, a sovereignty-focused layer that lets...
Three social platforms are drawing fresh attention as growth meets reasonable prices. Here’s a practical, investor-fr...
Chip stocks were crashing after a period of strong earnings, leaving many investors puzzled. This article unpacks why...